President Trump escalated efforts to reduce drug prices in the US on Thursday, releasing letters sent to 17 pharmaceutical ...

President Donald Trump sent letters to 17 of the world’s largest pharmaceutical companies — including Eli Lilly & Co., Novo ...

In letters sent to 17 major drugmakers, including Eli Lilly, Novo Nordisk and Pfizer, Trump called for immediate reductions in the prices charged to Medicaid for existing drugs and insisted that any ...

The White House cited data showing brand-name drugs in the United States are up to three times more expensive than identical drugs in other developed nations.

In 17 identical letters posted to his Truth Social account, the president said companies must lower their prices or the ...

Major pharma manufacturers have a 29 September deadline to adjust their drug prices relative to other developed countries.

The president threatened to “deploy every tool” in the administration’s arsenal if drug companies don’t cut certain prices by ...

Pfizer faces weak growth, sector headwinds, and pipeline uncertainty despite cost cuts and a 7% yield, weighing on sentiment.

Pfizer should have different top-selling drugs in 2030 with a heavier focus on oncology. The drugmaker should be more ...